Brazil’s public market access landscape is undergoing significant change. The recently approved CMED pricing resolution introduces important shifts to companies pursuing drug commercialization in Brazil.
Join our Better Market Access webinar to explore the latest regulatory developments and their strategic implications for pharmaceutical companies operating in Brazil.
This webinar will cover:
- The key changes introduced by the new CMED pricing resolution
- Which updates are still missing and are expected in the near future
- Strategic implications for drug launches and pricing strategies in Brazil
- How CMED dynamics are shaping the access environment
This webinar is free of charge. Don’t miss the opportunity to gain practical perspectives to help you anticipate risks and identify opportunities in Brazil’s evolving landscape.
Webinar details:
Thursday May 7, 2026
3:00 - 4:00 p.m. CEST | 9:00 - 10:00 a.m. EDT | 10:00 - 11:00 a.m. BRT
